The Valiant Laboratories IPO started on September 27, 2023, and ended on October 3, 2023. Shares were allocated on October 5, 2023, and refund processes began on October 6, 2023. On October 6, 2023, the shares were credited to investors demat accounts. Valiant Laboratories was officially listed on the stock exchange on October 9, 2023.
During the IPO, Valiant Laboratories offered shares at a price range of ₹133 to ₹140 per share, and the lot size was 105 shares. The total issue size was ₹152.46 crores, with ₹152.46 crores from new shares. The IPO was listed on both the NSE and BSE.
Regarding share reservations, 75% of the shares were allocated to Qualified Institutional Buyers (QIB), 15% were reserved for Non-Institutional Investors (NII), and 10% were set aside for retail investors.
Valiant IPO Subscription Update Video
Valiant Laboratories IPO Subscription Status
The Valiant Laboratories IPO on September 27, 2023 was subscribed 0.33 times, with the retail category being subscribed 0.62 times, the NII (Non-Institutional Investor) category being subscribed 0.10 times, the QIB (Qualified-Institutional Buyers) category being subscribed 0.00 times.
| Category | Subscription |
| QIB | 0.00x |
| NII | 0.10x |
| Retail | 0.62x |
| Total | 0.33x |
Valiant Laboratories IPO Basic Details
| Company Name | Valiant Laboratories Limited |
| Domain of Company | Pharmaceutical Company |
| Valiant Laboratories IPO Open Date | September 27, 2023 |
| Valiant Laboratories IPO Close Date | October 3, 2023 |
| Valiant Laboratories IPO Allotment Date | October 5, 2023 |
| Valiant Laboratories IPO Listing Date | October 9, 2023 |
| Face Value | ₹10 per share |
| Price | ₹133 to ₹140 per share |
| Lot Size | 105 Shares |
| Issue Size | 10,890,000 shares of ₹10 (aggregating up to ₹152.46 Cr) |
| Fresh Issue | 10,890,000 shares of ₹10 (aggregating up to ₹152.46 Cr) |
| Issue Type | Book Built Issue IPO |
| Listing At | NSE, BSE |
| Company Promoters | Shantilal Shivji Vora, Santosh Shantilal Vora, and Dhanvallabh Ventures LLP (DVL) |
About Valiant Laboratories Limited
Valiant Laboratories Limited, a pharmaceutical ingredient manufacturing company based in India, was founded in 1980 with a primary focus on producing Paracetamol.
Their manufacturing unit is situated in Palghar, Maharashtra, covering an area of 2,000 square meters, and it has an annual production capacity of 9,000 metric tons. Valiant Laboratories also boasts an R&D Facility, complete with an analytical laboratory and the necessary infrastructure for product development.
In the fiscal years 2023, 2022, and 2021, the company generated revenues of Rs. 3,339.10 million, Rs. 2,915.23 million, and Rs. 1,823.69 million, respectively.
Valiant Laboratories Limited sources the raw material, Para Amino Phenol, required for Paracetamol production from China and Cambodia through imports.
As of April 30, 2023, Valiant Laboratories employs 86 individuals.
Valiant Laboratories IPO Should you subscribe?
Valiant Laboratories IPO More Details Click Here
Valiant Laboratories IPO FAQs
What is the start and end date of Valiant Laboratories IPO Subscription?
The Valiant Laboratories IPO started on September 27, 2023, and ended on October 3, 2023.
When does Valiant Laboratories IPO Subscription open?
The Valiant Laboratories IPO open on September 27, 2023.
When does Valiant Laboratories IPO Subscription close?
The Valiant Laboratories IPO Close on October 3, 2023.
What is the allotment date of Valiant Laboratories IPO?
The allotment date for Valiant Laboratories IPO is October 5, 2023.
When is the initial refund date of Valiant Laboratories IPO?
The initial Refund date for Valiant Laboratories IPO is October 6, 2023.
When were the shares credited to investors demat accounts for the Valiant Laboratories IPO?
The shares for the Valiant Laboratories IPO were credited to investors demat accounts on October 6, 2023.
When will Valiant Laboratories IPO be listed on the stock market?
Valiant Laboratories IPO stock market will be listed on October 9, 2023 at 10 am.
What was the price range of the Valiant Laboratories IPO shares?
The Valiant Laboratories IPO shares were offered at a price range of ₹133 to ₹140 per share.
What was the lot size for the Valiant Laboratories IPO shares?
The lot size for the Valiant Laboratories IPO shares was 105 shares.
What was the total issue size of the Valiant Laboratories IPO?
The total issue size of the Valiant Laboratories IPO was ₹152.46 crores.
How were the shares allocated among different types of investors for the Valiant Laboratories IPO?
75% of the shares were allocated to Qualified Institutional Buyers (QIB), 15% were reserved for Non-Institutional Investors (NII), and 10% were set aside for retail investors.
On which stock exchanges was the Valiant Laboratories IPO listed?
The Valiant Laboratories IPO was listed on both the NSE and BSE.
What is the Valiant Laboratories IPO Subscription Status?
Valiant Laboratories IPO is subscribed Times.
